NATURAL ALTERNATIVES INTERNATIONAL INC NAII
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products
Chart by TradingView
4/9
Piotroski F — financial health
3.07
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $129.9M | -$13.6M | $9.3M | $2.3M | $68.4M |
| 2024 | $113.8M | -$7.2M | $6.9M | -$4.5M | $82.6M |
| 2023 | $154.0M | $2.5M | $18.2M | -$6.5M | $88.8M |
| 2022 | $171.0M | $10.7M | $30.5M | -$14.6M | $88.5M |
| 2021 | $178.5M | $10.8M | $30.4M | $15.7M | $80.1M |
| 2020 | $118.9M | -$1.6M | $18.9M | -$850,000 | $71.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| WOLF KENNETH | President, COO, & Sec. | 2026-03-06 | Grant | 15,000 | — |
| Fortin Michael E | Chief Financial Officer | 2026-03-06 | Tax withheld | 4,308 | $2.73 |
| Fortin Michael E | Chief Financial Officer | 2026-03-06 | Grant | 12,000 | — |
| LEDOUX MARK A | CEO/Chairman | 2026-03-06 | Tax withheld | 3,484 | $2.73 |
| LEDOUX MARK A | CEO/Chairman | 2026-03-06 | Grant | 20,000 | — |
| Dunn Alan G | director | 2026-03-06 | Grant | 8,000 | — |
| Matherly Laura Kay | director | 2026-03-06 | Grant | 8,000 | — |
| WOLF KENNETH | President, COO, & Sec. | 2026-03-06 | Tax withheld | 5,151 | $2.73 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.07 (safe)
- Working capital / assets 0.201
- Retained earnings / assets 0.391
- EBIT / assets -0.057
- Equity / liabilities 0.819
Source: SEC EDGAR filings · CIK 0000787253 · as of 2025-06-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.